WHAT IS THE INCIDENCE OF RETINOPATHY OF PREMATURITY (ROP) IN ‘BIG’ BABIES?: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY

ArticleAçık Erişim

Özet

Aim: This study aims to determine the incidence of ROP and to investigate its prognosis among premature babies with a BW of ≥2000 g. Material and Method: We retrospectively analyzed the data of 1004 babies with BW≥2000 g admitted to the ROP Diagnosis and Treatment Centers of X University Hospital and X Hospital between 2018 and 2019. Examination findings were recorded according to the Classification of Retinopathy of Prematurity guideline. We recorded the following information: GA, BW, type of delivery, oxygen therapy, age at the time of diagnosis (weeks), the location of ROP, the severity of ROP, vascular characteristics of ROP, treatment status, PMA, treatment modality, and retinal vascular development. Results: The 2008 eyes of 1004 subjects were included in the study. Mean GA (SD) of subjects was 34.3 (1.3) weeks (range: 31–36) and mean BW (SD) was 2377.3 (244.2) g (range: 2000–3400). The 283 eyes of 144 patients (14.1%, 95% CI: [11.7–17.3%]) had been diagnosed with ROP. We evaluated the location of ROP and found that it was in Zone II in 279 of the 283 eyes and in Zone I in 4 eyes. We found that 213 of the 283 eyes had stage 1 ROP, 53 eyes had stage 2 ROP, and 17 eyes had stage 3 ROP. According to the international ROP classification, 17 eyes of 9 patients had Type 1 ROP, and 266 eyes of 135 patients had Type 2 ROP in the study. Seventeen eyes (0.85%, 95%CI: [0.62–1.36%]) required treatment. Conclusion: We conclude that the incidence of ROP in babies with BW≥2000 g is higher in Turkey compared to developed countries. It is important to include these babies in the screening program as they can develop advanced ROP requiring treatment. © 2020, © 2020 Taylor & Francis Group, LLC.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13657Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorYildiz Ekinci, Dilbade
dc.contributor.authorUgurlu, Adem
dc.contributor.authorTasli, Nurdan Gamze
dc.date.accessioned2026-10-18T20:28:29.450935053Z
dc.date.available2026-10-18T20:28:29.450935053Z
dc.date.issued2020
dc.description.abstractAim: This study aims to determine the incidence of ROP and to investigate its prognosis among premature babies with a BW of ≥2000 g. Material and Method: We retrospectively analyzed the data of 1004 babies with BW≥2000 g admitted to the ROP Diagnosis and Treatment Centers of X University Hospital and X Hospital between 2018 and 2019. Examination findings were recorded according to the Classification of Retinopathy of Prematurity guideline. We recorded the following information: GA, BW, type of delivery, oxygen therapy, age at the time of diagnosis (weeks), the location of ROP, the severity of ROP, vascular characteristics of ROP, treatment status, PMA, treatment modality, and retinal vascular development. Results: The 2008 eyes of 1004 subjects were included in the study. Mean GA (SD) of subjects was 34.3 (1.3) weeks (range: 31–36) and mean BW (SD) was 2377.3 (244.2) g (range: 2000–3400). The 283 eyes of 144 patients (14.1%, 95% CI: [11.7–17.3%]) had been diagnosed with ROP. We evaluated the location of ROP and found that it was in Zone II in 279 of the 283 eyes and in Zone I in 4 eyes. We found that 213 of the 283 eyes had stage 1 ROP, 53 eyes had stage 2 ROP, and 17 eyes had stage 3 ROP. According to the international ROP classification, 17 eyes of 9 patients had Type 1 ROP, and 266 eyes of 135 patients had Type 2 ROP in the study. Seventeen eyes (0.85%, 95%CI: [0.62–1.36%]) required treatment. Conclusion: We conclude that the incidence of ROP in babies with BW≥2000 g is higher in Turkey compared to developed countries. It is important to include these babies in the screening program as they can develop advanced ROP requiring treatment. © 2020, © 2020 Taylor & Francis Group, LLC.
dc.identifier.doi10.1080/09286586.2020.1793372
dc.identifier.eissn1744-5086
dc.identifier.endpage6
dc.identifier.issn0928-6586
dc.identifier.issue2
dc.identifier.pmid32657188
dc.identifier.scopus2-s2.0-85087884044
dc.identifier.startpage1
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13657
dc.identifier.volume28
dc.identifier.wosWOS:000547671000001
dc.language.isoen
dc.publisherTaylor and Francis Ltd
dc.relation.ispartofOphthalmic Epidemiology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectbabies
dc.subjectbig
dc.subjectincidence
dc.subjectRetinopathy
dc.subjectrprematurity
dc.subjectBirth Weight
dc.subjectGestational Age
dc.subjectHumans
dc.subjectInfant, Newborn
dc.subjectInfant, Premature
dc.subjectNeonatal Screening
dc.subjectRetinopathy of Prematurity
dc.subjectRetrospective Studies
dc.subjectRisk Factors
dc.subjectbevacizumab
dc.subjectArticle
dc.subjectdisease severity
dc.subjectfemale
dc.subjecthuman
dc.subjectlaser coagulation
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmulticenter study
dc.subjectnewborn
dc.subjectoxygen therapy
dc.subjectpriority journal
dc.subjectprognosis
dc.subjectretrolental fibroplasia
dc.subjectretrospective study
dc.subjecttreatment duration
dc.titleWHAT IS THE INCIDENCE OF RETINOPATHY OF PREMATURITY (ROP) IN ‘BIG’ BABIES?: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus10
rdl.citation.wos10
rdl.departmentFaculty of Medicine, Department of Ophthalmology, Erzincan Binali Yildirim University, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)